Thank you for your interest in WEP Please see the resource below and check your inbox for the PDF version Managing patient requests for Your investigational medicines Are you receiving unsolicited requests for your phase [...]
Complete the form below and we will reach out to confirm your booking US +1 919-694-5088INFO@WEPCLINICAL.COM 951 AVIATION PARKWAY, SUITE 200, MORRISVILLE, NC, 27560 UK +44 208 004 8185INFO@WEPCLINICAL.COM CHISWICK TOWER, 389 CHISWICK HIGH ROAD, 14TH [...]
Navigating the Future of EU Joint Health Technology Assessments With the Health Technology Assessment (HTA) landscape undergoing transformation in January 2025, it's essential to prepare your pipeline for what lies ahead. Our Market Access team [...]
Early Access Programs allow patients and physicians to use investigational (pre-approval) drugs outside the clinical trial setting. They are often referred to as Expanded Access Programs (EAPs), Compassionate Use Programs (CUPs), or Managed Access [...]
">">With Every Patient At WEP, we are With Every Patient With this as our guiding principle, we operate as a Pharmaceutical Services Provider committed to delivering Drug Development, Treatment Access, and Commercialization Solutions for Sponsors [...]
Research Nursing for Decentralized Clinical Trials In 2021, WEP Clinical acquired Wren Healthcare, a clinical nursing solutions company. With the addition of Wren Healthcare, we now offer first-in-class Nursing Services for Decentralized Clinical Trials globally. To learn more [...]
COLLECTING REAL WORLD DATA IN EAPs We recognize the tremendous value Real World Data (RWD) can offer in the pre-approval space and work closely with our Sponsors to understand the opportunity for RWD collection in [...]
WHY COLLECT REAL WORLD DATA IN AN EXPANDED ACCESS PROGRAM? Expanded Access Programs (EAPs) provide sponsors the opportunity to collect meaningful Real World Data (RWD), i.e. data on health care that is [...]
Product Uptake By Country PA-NPPs adhere to strict legislation regarding the supply of unlicensed medicines on an unsolicited request basis. As such, there are many factors that determine the level of uptake in a PA-NPP, [...]
research nursing for decentralized clinical trials In 2021, WEP Clinical acquired UK-based clinical nursing solutions company Wren Healthcare. Wren’s already successful business model, coupled with WEP’s US nursing capabilities, allows us to offer [...]
